What we do
From target validation to clinical trials
Michigan Drug Discovery is a university-spanning collaboration to find, fund, and mentor drug discovery projects originating from faculty research across a sweeping range of disease areas. We support U-M investigators’ vast experience in areas of unmet medical needs with complementary expertise and technology in every step of the drug discovery process.
- bacterial and viral infections
- cardiovascular disease
- inflammatory disorders
- ophthalmologic disease
- metabolic disorders
- psychiatric disorders
- and many more
guidance, strategy, and coordination
What We Offer
Experienced guidance and mentorship through all stages of drug discovery and commercialization.
A one-stop entry point to university resources including:
assistance in securing intellectual property
guidance through the investigational new drug application process
development of clinical trials
connections to external partnership opportunities
Funding the future of drug discovery
Michigan Drug Discovery administers two funding mechanisms for drug discovery projects at U-M.
The MDD pilot grants provide a jump start for early stage projects and facilitate access to U-M’s high-throughput screening, structural biology, medicinal chemistry, and pharmacokinetics cores.
The SPARC-MDD Partnership provides financial support and industry resources to accelerate the development of potential new medicines for a wide range of diseases.
And we’re just one of many internal funding sources for drug discovery projects across the university.
Michigan Drug Discovery is jointly funded by the following U-M partners:
- College of Pharmacy
- Department of Internal Medicine
- Department of Pathology
- Life Sciences Institute
- Medical School Endowment for the Basic Sciences
- Office of the Provost
- Rogel Cancer Center